Becton Dickinson & Co. (NYSE:BDX) shares picked up nearly 3% today and hit a new 52-week high after the medical products maker reported a nearly 138% top-line gain during its fiscal 1st quarter, crushing Wall Street analysts’ forecasts along the way.
